Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 September 2025 | Story Martinette Brits | Photo Martinette Brits and Kaleidoscope Studios
GreenerSA
Jeminah Seqela from Food and Trees for Africa demonstrates tree planting as part of the initiative to plant 100 trees on the day.

The University of the Free State (UFS) launched Greener SA, a five-year initiative to plant 400 000 trees across South Africa, at the Paradys Experimental Farm on Friday 12 September 2025. Backed by the Mastercard Foundation through the TAGDev 2.0 programme and RUFORUM, the project brings together government, industry, students, and academics around a shared commitment to sustainability and food security. The launch was marked by the planting of the first 100 trees, a symbolic act that set the tone for the years ahead.

Prof Jan-Willem Swanepoel, Director of the Centre for Sustainable Agriculture, reminded the audience that the UFS is one of 12 African universities entrusted with a $100 million investment in agricultural transformation. “This project is not a hit-and-run – it’s about sustainability, inclusivity, and building value chains that empower farmers and entrepreneurs,” he said. He ended with a parable of a farmhand who could ‘sleep when the wind blows,’ urging everyone to be proactive in preparing for inevitable challenges.

 

Responsibility and partnerships

That call for responsibility was echoed by Elzabe Rockman, Free State MEC for Agriculture and Rural Development, who linked Greener SA to the presidential One Million Trees Programme. She cautioned that planting without accountability leads to wasted effort. “If we plant trees, we want to be sure someone takes responsibility for them,” she said, highlighting the need for fire-resistant species, fruit trees in community gardens, and natural borders to replace vulnerable fencing. Looking at the students from Kovsie ACT who joined the launch, she added: “Jobs are not going to fall from the sky. They will come from agriculture and the environment. Harnessing youth energy is the way forward.”

Industry also pledged its support. Representing Empact Group – the sponsor of the trees – Helena Prinsloo described tree planting as an investment in legacy. “At Empact Group, we believe that doing right by our community and our planet is not just a responsibility. It’s a value that defines who we are and how we lead,” she said. Quoting the proverb that societies grow great when people plant trees whose shade they will never sit in, she added: “Today we are sowing seeds of hope, resilience, and opportunities for generations to come.”

 

Science, vision, and practice

Prof Corli Witthuhn from the Faculty of Natural and Agricultural Sciences placed the launch in a global context, pointing to conflict, inequality, and climate change – and the sobering United Nations report showing that only 20% of the sustainability goals have been achieved. For her, the Greener SA project is a response to urgent global challenges. “We want our students to be globally work-ready,” she said. “That means beyond textbooks, and this farm represents exactly that. We don’t want to produce graduates with degrees, we want to produce graduates who can walk into a lab, into a policy meeting, into a business anywhere in the world and make an impact.”

Her message was supported by expert voices. Guest speaker Prof Ben du Toit from Stellenbosch University explained that agroforestry systems can simultaneously provide timber, food, biodiversity, and resilience. “Agroforestry is not planting trees over here and grazing over there – it’s about integration, so that benefits reinforce each other,” he said.

At the Paradys Experimental Farm, this integration is already underway. Johan Barnard, Farm Manager and Junior Lecturer, described how shaded tree pockets will improve grazing fields and protect water resources, while fruit trees planted in partnership with Kovsie ACT will contribute to student nutrition and new food value chains. “We’re capturing value chains and taking it to the next level so that our students have research opportunities and the farm delivers real outputs,” he explained.

The launch of Greener SA showed that tree planting is about much more than beautification. It is a collective commitment – to resilience in the face of global challenges, to science applied in practice, and to building partnerships that prepare the next generation to make an impact.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept